In this must-listen episode, Dr. Julia Moore Vogel at Scripps Research takes center stage to confer the still-emerging and always-evolving space of long COVID. As patient numbers continue to rise at an alarming rate, she makes a strong case about the critical need to better define the disease, mitigate its impact and, ultimately, break the taboo.

0:15 Introduction

1:27 Moore Vogel’s background in Long Covid

4:30 Lacking terminology in Long Covid

6:20 Quantifying Long Covid disease

8:38 The mechanism of action: what we know

10:27 Pediatric Long Covid

16:00 Similarities to post-viral syndromes

16:58 Key diagnostic tools

18:37 The current Long Covid treatment landscape

20:57 Influence of SARS-CoV-2 variants and vaccines

22:02 Considering social determinants of health

23:35 Needs for professional and public education

27:00 Final thoughts

28:28 Outro

Want more Lungcast? Visit us at HCPLive.com or Lung.org.